
About FutureCure
FutureCure is a Healthcare company based in Jaipur (India) founded in 2019 by Anita Bhandari and Rajneesh Bhandari. FutureCure has raised $14.96 million across 3 funding rounds from investors including Kotak Mahindra Bank, Unicorn India Ventures and Flair Pens. FutureCure was last valued at $44.08 million in September 2024. Its Indian entity Futurecure Health Private Limited reported revenue of βΉ17.31 Cr. Its focus areas include HealthTech, Healthcare IT, Value Based Care and Patient Engagement.
Company details
Provider of migraine treatment and digital therapeutics. It operates specialized clinics offering advanced technologies like Remote Electrical Neuro-Modulation (REN) and Transcutaneous Electrical Nerve Stimulation (TENS) for headache treatment. A team of neurologists, neuro-otologists, and psychologists provides detailed evaluations and treatment plans. The clinics also utilize a clinical decision support system for medication selection and a digital therapeutics app incorporating biofeedback for Cognitive Behavioral Therapy (CBT). This app supports lifestyle changes to manage migraine symptoms.
- Headquarters Jaipur, India
- Founders Anita Bhandari, Rajneesh Bhandari
- Stage Minicorn
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website futurecurehealth.com
- Legal Name Futurecure Health Private Limited
- Date of Incorporation 13 May, 2019
- Jurisdiction Jaipur, Rajasthan, India
- Annual Revenue₹17.31 Cr
FY 2025 · -6% YoY
- Net Loss-₹12.18 Cr
FY 2025 · -70% margin
- EBITDA-₹8.24 Cr
FY 2025 · -48% margin
- Total Equity Funding$14.96M (USD)
in 3 rounds
- Latest Funding Round$9.9M (USD), Series A
Sep 2024
- InvestorsKotak Mahindra Bank
& 13 more
Associated legal entities of FutureCure
FutureCure operates through Futurecure Health Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Futurecure Health Private Limited CIN U85320RJ2019PTC064908 | Active | 13 May 2019 | Jaipur, Rajasthan | ₹17.3 Cr | 249 | 4 | View details |
Funding Insights of FutureCure
FutureCure has successfully raised a total of $14.96M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $9.9 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $14.96M
- Total Rounds 3
- Last Round Series A β $9.9M
- First Round $1.06M
(Oct 2019)
- Investors Count 14
All 3 funding rounds of FutureCure with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2024 | $9.9M | Series A | $44.08M | Carnelian | |
| Mar 2022 | $4M | Series A | $14.59M | Unicorn India Ventures, Rajasthan Venture Capital Fund | |
| Oct 2019 | $1.06M | Seed | $β’β’β’β’β’ | Unicorn India Ventures | β |
| Date | Valuation | Stage |
|---|---|---|
| Sep 2024 | $44.08M | β’β’β’β’β’β’β’β’ |
| Mar 2022 | $14.59M | β’β’β’β’β’β’β’β’ |
| Oct 2019 | $β’β’β’β’β’ | β’β’β’β’β’β’β’β’ |
Full valuation and stage history of FutureCure
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $44.08M (Sep 2024). 14 investors in total: 9 institutional and 5 angel.
Investors in FutureCure
FutureCure has secured backing from 14 investors, including institutional, angel, and venture fund investors. Prominent investors backing the company include Kotak Mahindra Bank, Unicorn India Ventures and Flair Pens.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm offering seed funding and support to startups in technology and innovation sectors. | 2014 | unicornivc.com | Mumbai, India | |
Venture capital fund investing in multiple sectors | 2002 | rvcf.org | Jaipur, India | |
Investment management is conducted by Carnelian in capital markets. | carneliancapital.co.in | Mumbai, India | ||
A news channel network is operated from Jaipur, India. | rajasthanpatrika.com | Jaipur, India | ||
Provider of investment advisory services | Mumbai, India | |||
Brand of writing instruments | 1994 | flairpens.com | Mumbai, India | |
Woven plastic materials are manufactured by Plasti Weave Industries. | ||||
Commercial banking services are offered to corporate and retail customers. | 1985 | kotak.com | Mumbai, India | |
MM Mukul Mahavir Agrawal | unknown_e7f8f5c2da6548a59 |
Investor details for FutureCure
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Futurecure Health Private Limited (FutureCure)
Futurecure Health Private Limited is the primary company behind FutureCure. The board of Futurecure Health Private Limited currently have 4 directors; the longest-serving is Rajneesh Bhandari, appointed in 2019. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rajneesh Bhandari DIN 00094089 | Managing Director | 13 May 2019 | 7 yrs 6 mo | Futurecure Health Private Limited |
| Anita Bhandari DIN 08510326 | Director | 28 Aug 2020 | 6 yrs 2 mo | Futurecure Health Private Limited |
| Gaurav Chowdhry DIN 02695010 | Nominee Director | 11 Mar 2022 | 4 yrs 8 mo | Futurecure Health Private Limited |
| Deepak Malik DIN 10926010 | Nominee Director | 28 Jan 2025 | 1 yr 9 mo | Futurecure Health Private Limited |
People of FutureCure
2 people are tracked at FutureCure (2 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder & Director | Leadership | |
| Co-Founder & Managing Director | Leadership |
Complete people profiles for FutureCure
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of FutureCure
Figures of Futurecure Health Private Limited, the primary company behind FutureCure, for FY 2025. Revenue was ₹17.31 Cr (-6% year on year). Net loss was -₹12.18 Cr (-70% margin). EBITDA was -₹8.24 Cr (-48% margin). Revenue has grown at a compounded annual rate of +46% over three years and +37% over five years.
- ₹17.31 CrRevenue · FY 2025 · -6% YoY
- -₹12.18 CrNet loss · -70% margin
- -₹8.24 CrEBITDA · -48% margin
- ₹1.60 CrPaid-up capital
- 249Employees (provident fund records)
- +46%Revenue CAGR, 3 years
- +37%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Futurecure Health Private Limited are on its company page.
Detailed financial statements for FutureCure
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of FutureCure
4 dated milestones of FutureCure across 5 years, from founding to its latest funding, stage changes and deals.
- Founded FutureCure is founded.
- Funding First funding round of $1.1M.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Series A, of $9.9M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Futurecure
Complete news archive for FutureCure
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about FutureCure
FutureCure was founded in 2019.
FutureCure is headquartered in Jaipur, India. It is registered at Jaipur, Rajasthan, India.
FutureCure is a funded company, having raised a total of $14.96M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.06M, raised on Oct 2019.
The primary company behind FutureCure, Futurecure Health Private Limited, reported revenue of βΉ17.31 Cr for FY 2025, down 6% year on year.
Provider of migraine treatment and digital therapeutics. It operates specialized clinics offering advanced technologies like Remote Electrical Neuro-Modulation (REN) and Transcutaneous Electrical Nerve Stimulation (TENS) for headache treatment. A team of neurologists, neuro-otologists, and psychologists provides detailed evaluations and treatment plans. The clinics also utilize a clinical decision support system for medication selection and a digital therapeutics app incorporating biofeedback for Cognitive Behavioral Therapy (CBT). This app supports lifestyle changes to manage migraine symptoms.
FutureCure has 14 investors. Key investors include Kotak Mahindra Bank, Unicorn India Ventures, Flair Pens, Rajasthan Venture Capital Fund, and Carnelian.
The valuation of FutureCure is $44.08M as of Sep 2024.
FutureCure operates through Futurecure Health Private Limited.
The legal entities of FutureCure currently have 4 directors, including Anita Bhandari, Gaurav Chowdhry, Rajneesh Bhandari and others.
